Tue, August 10, 2021
Mon, August 9, 2021
Fri, August 6, 2021
Thu, August 5, 2021
Wed, August 4, 2021

Brian Abrahams Maintained (BCRX) at Hold with Increased Target to $16 on, Aug 6th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-16-on-aug-6th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Brian Abrahams of RBC Capital, Maintained "BioCryst Pharmaceuticals, Inc." (BCRX) at Hold with Increased Target from $13 to $16 on, Aug 6th, 2021.

Brian has made no other calls on BCRX in the last 4 months.



There is 1 other peer that has a rating on BCRX. Out of the 1 peers that are also analyzing BCRX, 0 agree with Brian's Rating of Hold.



This is the rating of the analyst that currently disagrees with Brian


  • Brian Cheng of "Cantor Fitzgerald" Initiated at Buy and Held Target at $21 on, Tuesday, August 3rd, 2021

Publication Contributing Sources